CompletedPHASE2, PHASE3NCT00304135
Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
Studying Carcinoma of gallbladder and extrahepatic biliary tract
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Federation Francophone de Cancerologie Digestive
- Principal Investigator
- Bruno ChauffertCentre Georges Francois Leclerc
- Intervention
- cisplatin(drug)
- Enrollment
- 34 enrolled
- Eligibility
- 18-120 years · All sexes
- Timeline
- 2005 – 2012
Study locations (20)
- Centre Hospitalier General, Belfort, France
- Centre Hospitalier Pierre Oudot, Bourgoin, France
- Hopital Louis Pasteur, Colmar, France
- Centre Hospitalier de Dax, Dax, France
- Hopital Du Bocage, Dijon, France
- Centre de Lutte Contre le Cancer Georges-Francois Leclerc, Dijon, France
- Centre Hospitalier Departemental, La Roche-sur-Yon, France
- C. H. Du Mans, Le Mans, France
- CHU de la Timone, Marseille, France
- Centre Hospitalier General de Mont de Marsan, Mont-de-Marsan, France
- CHR D'Orleans - Hopital de la Source, Orléans, France
- Hopital Bichat - Claude Bernard, Paris, France
- CHU Pitie-Salpetriere, Paris, France
- Centre Hospitalier Lyon Sud, Pierre-Bénite, France
- Hopital Sebastopol, C.H.U. de Reims, Reims, France
- +5 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00304135 on ClinicalTrials.govOther trials for Carcinoma of gallbladder and extrahepatic biliary tract
Additional recruiting or active studies for the same condition.
- ENROLLING BY INVITATIONPHASE2NCT06901622Camrelizumab and Chemotherapy With or Without Anlotinib as First-line Treatment for Advanced Gallbladder Cancer and Extrahepatic CholangiocarcinomaThe First Affiliated Hospital of Zhengzhou University
- RECRUITINGNCT07337850Prospective Evaluation of 68Ga-FAPI PET in Biliary CancersTata Memorial Centre
- RECRUITINGPHASE2NCT06440993Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic CholangiocarcinomaInstitut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
- ACTIVE NOT RECRUITINGPHASE2NCT05712356A Study of LSTA1 When Added to Standard of Care Versus Standard of Care Alone in Patients With Advanced Solid TumorsLisata Therapeutics, Inc.
- ENROLLING BY INVITATIONPHASE3NCT06671418Primary Percutaneous Stenting Above the Ampulla Versus Endoscopic Drainage for Unresectable Malignant Hilar Biliary ObstructionErasmus Medical Center
- RECRUITINGNCT05404347NGS in Gallbladder Cancer and Response to TreatmentBanaras Hindu University
See all trials for Carcinoma of gallbladder and extrahepatic biliary tract →